DCA Vantage

The Association of Multidimensional Sleep Health With HbA1c and Depressive Symptoms in African American Adults With Type 2 Diabetes.

Estimating the Rates of Undiagnosed Prediabetes and Diabetes Among People Experiencing Homelessness.

Validation and feasibility of a postal system for remote monitoring of HbA1c.

Experience of point-of-care HbA1c testing in the English National Health Service Diabetes Prevention Programme: an observational study.

Effect of hemoglobin N Baltimore on HbA1c measurement in six methods.

Quality Control of Norwegian Pharmacy HbA1c Testing: A Modest Beginning.

Results from 15years of quality surveillance for a National Indigenous Point-of-Care Testing Program for diabetes .

Diabetes and pre-diabetes in tuberculosis patients in western Kenya using point-of-care glycated haemoglobin.

Improvement in the Quality of HbA1c Determination by Using Commutable Specimens With IFCC-Assigned Values.

Implementation of POCT in the diabetic clinic in a large hospital.

Hb Tacoma is difficult to detect and may cause false results with different HbA1c methods.

A comparison of fetal hemoglobin interference in routine high-performance liquid chromatography, immunoassay, and enzymatic methods of glycated hemoglobin measurement.

Feasibility and Performance of Hemoglobin A1C Self-Testing During COVID-19 Among African Americans With Type 2 Diabetes.

Assessment of two glycated hemoglobin immunoassays.

HbA1c-testing: Evaluation of two point-of-care analysers.

Assessment of Two Diabetes Point-of-care Analyzers Measuring Hemoglobin A1c in the Peruvian Amazon.

Long-Term Performance of Point-of-Care Hemoglobin A1c Assays.

Accuracy of three hemoglobin A1c point-of-care systems for glucose monitoring in patients with diabetes mellitus.

Selecting an A1C Point-of-Care Instrument.

Three of 7 hemoglobin A1c point-of-care instruments do not meet generally accepted analytical performance criteria.

High Prevalence of Hb Riccarton Challenges HbA1c Analysis in a Danish Clinical Laboratory Using the Tosoh G11.

Reply to letter from Mayfield et al. regarding "Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage™ HbA1c POCT instrument in a true clinical setting".

Reply to Abildgaard et al.: lot variation and inter-device differences contribute to poor analytical performance of the DCA vantage™ HbA1c POCT instrument in a true clinical setting.

A case of inter-assay HbA1c discrepancy due to Hemoglobin G-Copenhagen.

Biomarkers in diabetes mellitus: contributions and discrepancies of new technologies. A case report.

Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage™ HbA1c POCT instrument in a true clinical setting.

Comparison of Point-of-Care Testing and Hospital-Based Methods in Screening for Potential Type 2 Diabetes Mellitus and Abnormal Glucose Regulation in a Dental Setting.

Level of agreement of point-of-care and laboratory HbA1c measurements in the preoperative outpatient clinic in non-diabetic patients who are overweight or obese.

Agreement between the 'point of care' tests for microalbuminuria and HbA1c performed in mexican family medicine units and the results of standard laboratory tests.

Retrospective Analysis of Point-of-Care and Laboratory-Based Hemoglobin A1c Testing.

Evaluating point-of-care testing for glycosylated haemoglobin in public sector primary care facilities in the Western Cape, South Africa.

Point-of-Care Hemoglobin A1c Testing: A Budget Impact Analysis.